Fig. 3From: TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinomaExploration of the 11-gene model. (a) GSEA revealed the signaling pathways enriched in the high-risk group. (b) Comparison of the ssGSEA score of signatures in the high- and low-risk score patients in TCGA cohorts. (c) nomogram used for prediction of LNM in male PTC patients. (d) The ROC of the TIPARP (AUC = 0.692)Back to article page